ロード中...
Current approaches to the initial treatment of symptomatic multiple myeloma
The treatment of newly diagnosed multiple myeloma has dramatically changed since the emergence of proteasome inhibitors and immunomodulatory drugs. Front-line combination regimens incorporating novel drugs such as thalidomide, bortezomib and lenalidomide, have significantly improved response rates a...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3839860/ https://ncbi.nlm.nih.gov/pubmed/24286003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/ijh.13.3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|